These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 18836203

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
    Vincent-Salomon A, Jouve M, Genin P, Fréneaux P, Sigal-Zafrani B, Caly M, Beuzeboc P, Pouillart P, Sastre-Garau X.
    Cancer; 2002 Apr 15; 94(8):2169-73. PubMed ID: 12001113
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
    Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS.
    Cancer Res; 2007 May 01; 67(9):4190-8. PubMed ID: 17483330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
    Bensouda Y, André F, Boulet T, Al-Ghuzlan A, Conforti R, Troalen F, Bourgier C, Errihani H, Spielmann M, Delaloge S.
    Bull Cancer; 2009 Oct 01; 96(10):923-8. PubMed ID: 19696005
    [Abstract] [Full Text] [Related]

  • 7. [Visceral metastasis in 135 cases of breast cancer: evaluation at autopsy].
    Nakamura T, Sakamoto G, Kitagawa T, Kasuga T, Sugano H.
    Gan No Rinsho; 1983 Dec 01; 29(15):1717-20. PubMed ID: 6668670
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
    Broom RJ, Tang PA, Simmons C, Bordeleau L, Mulligan AM, O'Malley FP, Miller N, Andrulis IL, Brenner DM, Clemons MJ.
    Anticancer Res; 2009 May 01; 29(5):1557-62. PubMed ID: 19443366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
    Amir E, Ooi WS, Simmons C, Kahn H, Christakis M, Popovic S, Kalina M, Chesney A, Singh G, Clemons M.
    Clin Oncol (R Coll Radiol); 2008 Dec 01; 20(10):763-8. PubMed ID: 18824337
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Postoperative brain metastasis from esophageal carcinomas: report of 4 cases].
    Kaneko T, Hirao M, Shimada M, Takayama T, Iwazawa T, Murata K, Inoue M, Terashima T, Mizunoya S, Okagawa K.
    Kyobu Geka; 1991 Nov 01; 44(12):1013-7. PubMed ID: 1758102
    [Abstract] [Full Text] [Related]

  • 18. [Distribution of lung cancer metastases. I. Combination and frequency of organ metastases].
    Barz H, Barz D, Klemm P.
    Arch Geschwulstforsch; 1982 Nov 01; 52(7):551-60. PubMed ID: 7165490
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 01; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.